These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18548129)

  • 1. Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis.
    Zhang J; Lu A; Beech D; Jiang B; Lu Y
    Cancer Ther; 2007; 5():273-286. PubMed ID: 18548129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Breast Tumor Cell Growth by Ectopic Expression of p16/INK4A Via Combined Effects of Cell Cycle Arrest, Senescence and Apoptotic Induction, and Angiogenesis Inhibition.
    Lu Y; Zhang X; Zhang J
    J Cancer; 2012; 3():333-44. PubMed ID: 22866168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 Modulates VEGF expression via its interaction with HIF-1alpha in breast cancer cells.
    Zhang J; Lu A; Li L; Yue J; Lu Y
    Cancer Invest; 2010 Jul; 28(6):588-97. PubMed ID: 20307196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells.
    Li L; Lu Y
    J Cancer; 2010 Sep; 1():126-35. PubMed ID: 20922054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition.
    Al-Ansari MM; Hendrayani SF; Tulbah A; Al-Tweigeri T; Shehata AI; Aboussekhra A
    Neoplasia; 2012 Dec; 14(12):1269-77. PubMed ID: 23308058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
    Matsui J; Funahashi Y; Uenaka T; Watanabe T; Tsuruoka A; Asada M
    Clin Cancer Res; 2008 Sep; 14(17):5459-65. PubMed ID: 18765537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
    Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limonin inhibits angiogenesis and metastasis of human breast cancer cells by suppressing the VEGFR2/IGFR1-mediated STAT3 signaling pathway.
    Chen J; Liu BX; Shen Q; Li N; Ling J; Xiao M; Jiao HY; Li T
    Transl Cancer Res; 2020 Nov; 9(11):6820-6832. PubMed ID: 35117291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer cells-derived Von Willebrand Factor promotes VEGF-A-related angiogenesis through PI3K/Akt-miR-205-5p signaling pathway.
    Tao Q; Qi Y; Gu J; Yu D; Lu Y; Liu J; Liang X
    Toxicol Appl Pharmacol; 2022 Apr; 440():115927. PubMed ID: 35192807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells.
    Shibata A; Nagaya T; Imai T; Funahashi H; Nakao A; Seo H
    Breast Cancer Res Treat; 2002 Jun; 73(3):237-43. PubMed ID: 12160329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
    Bachelier R; Confavreux CB; Peyruchaud O; Croset M; Goehrig D; van der Pluijm G; Clézardin P
    Int J Cancer; 2014 Sep; 135(6):1319-29. PubMed ID: 24615579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.
    Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K
    Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer.
    Li X; Gao Y; Li J; Zhang K; Han J; Li W; Hao Q; Zhang W; Wang S; Zeng C; Zhang W; Zhang Y; Li M; Zhang C
    Cell Death Dis; 2018 Jul; 9(7):744. PubMed ID: 29970908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
    Cai S; Han K
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
    Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
    Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence.
    Wang D; Xiao F; Feng Z; Li M; Kong L; Huang L; Wei Y; Li H; Liu F; Zhang H; Zhang W
    Breast Cancer Res; 2020 Sep; 22(1):103. PubMed ID: 32993785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.